Radius Health. has been granted a patent for estrogen receptor modulators, including specific compounds and pharmaceutical compositions. These modulators are intended for treating diseases related to estrogen receptors, either alone or in combination with other treatments. GlobalData’s report on Radius Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Radius Health, Microneedles for transdermal drug delivery was a key innovation area identified from patents. Radius Health's grant share as of July 2024 was 38%. Grant share is based on the ratio of number of grants to total number of patents.
The patent US12018019B2 encompasses a series of claims related to specific chemical compounds, particularly those represented by a defined formula I'. The claims detail various structural configurations of these compounds, including specific substituents and functional groups. Notably, claims 2 through 10 elaborate on the variations of the compound, specifying the nature of substituents such as W, A, Y, Z, and others, which can include elements like ethylamino, cyclopropylmethyl, and isopropylphenyl. Additionally, claim 11 lists several specific compounds that fall under the broader category defined in claim 1, indicating their potential applications in pharmaceutical formulations.
Furthermore, the patent outlines methods for utilizing these compounds in medical treatments. Claims 12 through 14 describe a pharmaceutical composition that includes the compounds and a pharmaceutically acceptable excipient. The methods proposed involve administering these compounds to treat conditions associated with estrogen levels, as well as various types of cancer, including prostate, breast, and ovarian cancers. This suggests a therapeutic potential for the compounds in addressing hormonal imbalances and specific malignancies, thereby highlighting their significance in the field of medicinal chemistry and oncology.
To know more about GlobalData’s detailed insights on Radius Health, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
